Systematic Reclassification of Variants of Uncertain Significance in a Clinical Nephrogenomics Program: Insights from the RAPIDS Collaboration

Clicks: 2
ID: 338250
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #228 of 228 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 228 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background A nationwide nephrologist-led genetic testing program for suspected monogenic glomerular disease and unexplained chronic kidney disease was implemented across four tertiary hospitals in Singapore. Initial testing yielded a genetic diagnosis in 11.5% probands, while 77 (18.4%) harboured variants of uncertain significance (VUS) that could explain their kidney disease (VUS-congruent). We evaluated a structured pipeline for reclassifying VUS-congruent to likely pathogenic or pathogenic (LP/P) to improve diagnostic yield and clinical utility. Methods Probands with VUS-congruent were reviewed at monthly multidisciplinary genomic board meetings. A stepwise framework incorporated genotype–phenotype correlations (Step 1), then re-appraisal of existing evidence (Step 2) through review of population databases, literature and in-silico prediction. For VUS with high suspicion of pathogenicity (VUS-High), resolution strategies were recommended (Step 3), including familial variant-specific testing, deeper phenotyping, and functional studies. Primary outcome was the proportion of VUS-congruent reclassified to LP/P; secondary outcomes were improvements in diagnostic yield and clinical utility. Results Among 418 probands tested over 28 months, 77 (18.4%) had VUS-congruent. Step 2 reclassified 26/77 VUS-congruent to LP/P, with another 22/77 VUS-congruent stratified as VUS-High. Among these 22 recommended for Step 3, completed strategies were functional studies (n=8), segregation analysis (n=1), deeper phenotyping (n=1), phase determination (n=1) and combination strategies (n=6). This enabled VUS-High reclassification to LP/P for 16 additional probands. Overall, 42/77 probands (54.5%) had VUS-congruent reclassified to LP/P, increasing diagnostic yield from 11.5% to 21.5%. Among these, 28 (66.7%) experienced clinically meaningful management changes. Conclusion A structured, multidisciplinary VUS resolution workflow enabled considerable VUS reclassification, nearly doubling the diagnostic yield.
Reference Key
openalex_W7225110386 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tung Lin Lee, 张耀春, Tina Si Ting Lim, Chee Teck Koh, Kay Yuan Chong, Christina Titin, Hui Zhuan Tan, Irene Y. J. Mok, Jia Liang Kwek, Cynthia Ciwei Lim, Jason Chon Jun Choo, Jeannette Goh, Sylvia Kam, Breana Cham, Jiin Ying Lim, Ee Shien Tan, Esther Huimin Leow, Yong Hong Ng, Jia Ying Celeste Yap, Sing Ming Chao, Siew Le Chong, Ru Sin Lim, Su Mein Goh, Regina Shaoying Lim, See Cheng Yeo, Ziyin Wang, Chia Wei Lim, Dana Leng Hui Chan, David Lu, Sharon Teo, Perry Y W Lau, Mya Than, Jun Li Ng, Gek Cher Chan, Yi Da, Boon Wee Teo, Hui‐Kim Yap, Hui-Lin L. Chin, Kar Hui Ng
Are you one of these authors? Claim your profile
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag397
URL
https://doi.org/10.1093/ckj/sfag397
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.